The Alzheimer disease market

Nat Rev Drug Discov. 2015 Oct;14(10):675-6. doi: 10.1038/nrd4749. Epub 2015 Sep 21.

Authors

XiaoXiao Qian¹, Bashar Hamad¹, Gus Dias-Lalcaca¹

Affiliation

¹ IMS Health, 210 Pentonville Road, London, N1 9JY, UK.

PMID: 26388231
DOI: 10.1038/nrd4749

No abstract available

Publication types

News

MeSH terms

Alzheimer Disease / drug therapy*
Amyloid Precursor Protein Secretases / antagonists & inhibitors
Antibodies, Monoclonal / therapeutic use
Antibodies, Monoclonal, Humanized / therapeutic use
Aspartic Acid Endopeptidases / antagonists & inhibitors
Drug Discovery*
Humans
Receptor for Advanced Glycation End Products / antagonists & inhibitors

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Receptor for Advanced Glycation End Products
aducanumab
gantenerumab
Amyloid Precursor Protein Secretases
Aspartic Acid Endopeptidases
BACE1 protein, human